广发纳斯达克生物科技人民币(001092)
动态评分: 5.28分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2019-12-31 | AVDL | Avadel Pharmaceuticals plc ADR | 6.28 | 0.04% |
2019-12-31 | BCRX | BioCryst Pharmaceuticals Inc | 6.75 | 0.04% |
2019-12-31 | CRBP | Corbus Pharmaceuticals Holdings Inc | 6.2 | 0.04% |
2019-12-31 | CTMX | CytomX Therapeutics Inc | 6.45 | 0.04% |
2019-12-31 | DBVT | DBV Technologies SA ADR | 5.69 | 0.04% |
2019-12-31 | IBRX | ImmunityBio Inc | 6.13 | 0.04% |
2019-12-31 | INO | Inovio制药 | 5.95 | 0.04% |
2019-12-31 | JNCE | Jounce Therapeutics Inc | 5.65 | 0.04% |
2019-12-31 | PBYI | Puma Biotechnology Inc | 6.59 | 0.04% |
2019-12-31 | RIGL | Rigel Pharmaceuticals Inc | 6.93 | 0.04% |
2019-12-31 | CALA | Calithera Biosciences Inc | 4.07 | 0.03% |
2019-12-31 | CLXT | Calyxt Inc | 4.42 | 0.03% |
2019-12-31 | CNCE | Concert Pharmaceuticals Inc | 4.32 | 0.03% |
2019-12-31 | ELAN | Elanco Animal Health Inc | 4.99 | 0.03% |
2019-12-31 | GERN | 杰龙 | 4.66 | 0.03% |
2019-12-31 | GLYC | GlycoMimetics Inc | 4.48 | 0.03% |
2019-12-31 | NERV | Minerva Neurosciences Inc | 5.49 | 0.03% |
2019-12-31 | SNDX | Syndax Pharmaceuticals Inc | 4.35 | 0.03% |
2019-12-31 | ABUS | Arbutus Biopharma Corp | 3.2 | 0.02% |
2019-12-31 | CLLS | Cellectis SA ADR | 3.77 | 0.02% |
公告&资料
